Minneapolis, MN, United States of America

Luke J Ryves

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Metascape LLC. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luke J Ryves. Retrieved from https://idiyas.com/inventor/luke-j-ryves

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luke J Ryves - Innovator in Inhibitory Cell Adhesion Surfaces

Introduction

Luke J Ryves is an inventor based in San Francisco, CA (US). He has made significant contributions to the field of medical implants through his innovative research. His work focuses on developing nanostructured surfaces that are highly resistant to cell adhesion, which is crucial for improving the performance of medical devices.

Latest Patent Applications

Luke J Ryves has submitted a patent application titled "INHIBITORY CELL ADHESION SURFACES." This application describes nanostructured surfaces on selected substrates that inhibit fibroblast adhesion, particularly on nanorough titanium deposited on smooth silicone surfaces. The engineered metal coatings can be designed to ensure that various cell types, including endothelial, osteoblast, and fibroblast cells, show minimal tendency to attach to the coated surface in vivo.

Conclusion

Luke J Ryves is an innovative inventor whose work on inhibitory cell adhesion surfaces has the potential to enhance the functionality of medical implants. His research is paving the way for advancements in the field of biomedical engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…